The News
Jeff Kolstad joins Avantium as Chief Scientist to accelerate bioplastics development
05/08/2011
August 5, 2011 - Amsterdam, the Netherlands
Today Avantium announced that Dr. Jeffrey J. Kolstad has joined Avantium as Chief Scientist. Jeff Kolstad will strengthen Avantium’s team in developing a next generation of bioplastics on the basis of its YXY technology. Previously Chief Scientist at NatureWorks (formerly Cargill-Dow) he was one of the founding team members for developing and commercializing PLA (polylactic-acid), a biobased polymer. The team developed the process and polymer technology, moving it from laboratory scale, to pilot plant, into a fully commercial 140,000 MT/yr manufacturing facility in Blair, Nebraska, USA. Jeff was also responsible for managing the intellectual property portfolio and IP strategy of NatureWorks. Prior to NatureWorks, Jeff worked in the Corporate Research centers at Cargill,Inc. and Amoco Oil Company. He holds a PhD in Chemical Engineering from the Princeton University. Tom van Aken, CEO of Avantium: “Jeff brings highly valuable expertise and experience to Avantium in the field of biopolymer development. He is one of the few experts in the world who has firsthand experience in bringing a new biobased plastic to the market. Jeff will be a great asset for Avantium when we work towards the commercialization of our YXY technology for bioplastics in a range of applications and end markets”.
”I am excited to be joining Avantium at this stage of the YXY development,” said Jeff Kolstad. “These new materials take full advantage of the opportunity brought by a renewable, carbohydrate based feedstock. We have the potential to develop new polymers at a competitive price, with improved performance relative to their petrochemical based counterparts, while maintaining a high carbon efficiency.” Avantium is developing its YXY technology for the cost effective production of Furanics building blocks. The company is building a pilot plant to demonstrate its YXY technology and to produce larger volumes of YXY building blocks for application development of new, green plastics, chemicals and materials. Earlier this year, Avantium announced that is actively developing PEF, a 100% renewable and 100% recyclable polyester as alternative to petroleum based PET. Avantium has also partnered with Solvay for the development of green polyamides for engineering plastics and with Teijin Aramid for the development of green high-performance fibers.
This email (including its attached files and other content) is confidential and intended only for the use by named addressee. Unauthorized use, dissemination, disclosure and/or copying are prohibited. This email, attachments and (any part of) its content are (1) intended for the named addressee(s) only, and (2) strictly confidential and proprietary. All rights are reserved by Avantium Holding B.V. and its subsidiaries (‘Avantium’). Any unauthorized use, dissemination, disclosure and/or copying is strictly prohibited, except after prior and express written permission by Avantium. Avantium is not responsible for the correct transmission and timely receipt of this email and its content. Should you have received this email, attachments and its content by mistake, please bring this to our attention and destroy this email in full. Thank you.
2011
- 05/01/2011
-
05/01/2011
Sofinnova Partners announces the promotion of two of its team members:
-
05/01/2011
Sofinnova Parnters annonce la promotion de deux membres de son équipe:
- 05/01/2011
- 18/01/2011
- 19/01/2011
- 27/01/2011
-
07/02/2011
McPhy Energy signs contract with Enel Group for solid hydrogen storage
-
07/02/2011
McPhy Energy signe un contrat de fourniture de stockage hydrogène avec le groupe Enel
- 02/03/2011
-
02/03/2011
McPhy Energy to supply solid hydrogen storage solution to Iwatani Corporation, Japan's market leader
-
02/03/2011
blueKiwi annonce la nomination de Jean-Luc Valente au poste de President Directeur Général
-
02/03/2011
blueKiwi lance sa nouvelle offre modulaire de réseaux sociaux professionnels
- 05/03/2011
-
14/03/2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding
- 14/03/2011
- 10/03/2011
- 30/03/2011
- 30/03/2011
- 18/04/2011
- 26/04/2011
- 21/04/2011
-
04/05/2011
BioAmber Closes USD45 Million Series B to Fund Succinic and Adipic Platforms
-
05/05/2011
Fundraising round beckons for Taptu as it releases Android tablet app
- 11/05/2011
- 10/05/2011
- 17/05/2011
- 20/05/2011
- 17/05/2011
-
25/05/2011
Google a une vision hégémonique et caricaturale de l'internet européen
- 31/05/2011
- 30/05/2011
- 15/06/2011
- 22/06/2011
- 27/06/2011
-
24/06/2011
Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. As Chief Operating Officer
-
11/07/2011
Solvay and Avantium to jointly develop green engineering plastics
- 06/07/2011
- 06/07/2011
- 04/08/2011
-
05/08/2011
Jeff Kolstad joins Avantium as Chief Scientist to accelerate bioplastics development
-
08/09/2011
Qosmos Closes €19.8 Million Funding Round with DFJ Esprit, FSI and Alven Capital
-
14/09/2011
BioAmber Partners with PTTMCC Biochem for PBS production in Thailand
-
16/09/2011
Plus de 1 00 00 patients ont bénéficié de la technologie auto¬apposante de STENTYS
-
13/09/2011
OpenERP among 20 Hot International Startups You Need To Watch
- 20/09/2011
- 21/09/2011
- 08/09/2011
-
17/10/2011
Hookipa Biotech Closes €7 million Series A Financing Led by Sofinnova Partners
-
14/11/2011
BioAmber Strengthens its Management Team and Board of Directors
- 22/11/2011
- 29/11/2011
-
30/11/2011
Ablynx reports positive Phase I data for ALX-0061 in rheumatoid arthritis
- 06/12/2011
-
06/12/2011
DBV Technologies proudly welcomes Mr. David Schilansky as its new Chief Financial Officer
-
13/12/2011
Ablynx initiates Phase I study with ALX-0171 for the treatment of respiratory syncytial virus (RSV)